Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1583PDF: 800HTML: 158 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1441PDF: 751Suppl. Files: 320Html: 132 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1967PDF: 1109HTML: 610 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1452PDF: 761HTML: 198 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4773PDF: 1791HTML: 2125 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
139PDF: 156Suppl. Files: 32HTML: 11 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1169PDF: 748HTML: 1342Figure 1: 185Figure 2: 188 -
Osteolytic bone lesions – A rare presentation of AML M6.
1961PDF: 1090HTML: 7915Untitled: 202 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2865PDF: 1094HTML: 3027 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2558PDF: 734HTML: 2295 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1076PDF: 418HTML: 236 -
How I treat acute and persistent sickle cell pain
1899PDF: 1110HTML: 477 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1040PDF: 1037HTML: 93 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1207PDF: 754HTML: 306 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3276PDF: 2261HTML: 23314Untitled: 201Untitled: 212Untitled: 227 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1344PDF: 520HTML: 194 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1992PDF: 756HTML: 3111 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1373PDF: 814HTML: 3115 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12318PDF: 1670HTML: 4161Cover letter: 195Figure 1: 201 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1811PDF: 902HTML: 951Referring article: 748 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1583PDF: 577HTML: 220 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3520PDF: 1472HTML: 4377CoverLetter: 183Figure1: 194







